Sulfuric Acid

Sulfuric Acid

SCHEMBL6049591

CCN=C(N)N.O=S(=O)(O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 3/20 0.50
KDM4E B2RXH2 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
HSD17B10 Q99714 1/20 0.50
PMP22 Q01453 2/20 0.48
ALOX15 P16050 1/20 0.41
NOS1 P29475 1/20 0.40
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
TP53 P04637 1/20 0.33
CA5A P35218 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
F2 P00734 1/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL689417 0.85
Hydrochloric Acid SCHEMBL6777486 0.82
Sulfuric Acid SCHEMBL11555534 0.75 HSD17B10 (0.44) BLMKDM4ENPSR1HSD17B10PMP22
Sulfuric Acid SCHEMBL11555536 0.75 HSD17B10 (0.44) BLMKDM4ENPSR1HSD17B10PMP22
Sulfuric Acid SCHEMBL6598917 0.75 MEN1 (0.64) BLMNPSR1PMP22ALOX15MEN1
Sulfuric Acid SCHEMBL11558562 0.74 NOS1 (0.48) BLMKDM4ENPSR1HSD17B10PMP22
Sulfuric Acid SCHEMBL11558559 0.74 NOS1 (0.48) BLMKDM4ENPSR1HSD17B10PMP22
Sulfuric Acid SCHEMBL11562779 0.74 NPSR1 (0.47) BLMKDM4ENPSR1HSD17B10PMP22
Sulfuric Acid SCHEMBL11557630 0.74 MEN1 (0.75) BLMNPSR1PMP22ALOX15MEN1
Sulfuric Acid SCHEMBL11562775 0.74 NPSR1 (0.47) BLMKDM4ENPSR1HSD17B10PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117865165-B Preparation method and application of ultra-small particle and high-stability silicon dioxide colloid 山东科翰硅源新材料有限公司 2024-09-17 CN disclosed
CN-117865165-A Preparation method and application of ultra-small particle and high-stability silicon dioxide colloid 山东科翰硅源新材料有限公司 2024-04-12 CN disclosed
CN-111978262-B Synthesis method of hydroxypyrimidine compound 西安近代化学研究所 2023-07-18 CN disclosed
CN-115403527-A Method for synthesizing bactericide ethirimol by reductive amination method 西安近代化学研究所 2022-11-29 CN disclosed
CN-111978262-A Synthetic method of hydroxypyrimidine compound 西安近代化学研究所 2020-11-24 CN disclosed
EP-1681058-A2 Pharmacologically active cns compounds THE WELLCOME FOUNDATION LIMITED (GB) 2006-07-19 EP disclosed
EP-1325916-A1 Piperazinyl-substituted phenyl pyrimidine derivatives useful in the treatment or prevention of disorders of the central nervous system THE WELLCOME FOUNDATION LIMITED (GB) 2003-07-09 EP disclosed
EP-0859762-A1 CYTOKINE PRODUCTION INHIBITORS, FORMULATIONS THEREOF AND THEIR USE IN MEDICINE, AND METHODS FOR THEIR IDENTIFICATION WIVENHOE TECHNOLOGY LIMITED (GB) 1998-08-26 EP disclosed
US-5712276-A TREATING NERVOUS SYSTEM DISORDERS GLAXO WELLCOME INC. (US) 1998-01-27 US disclosed
WO-1997045417-A1 CYTOKINE PRODUCTION INHIBITORS, FORMULATIONS THEREOF AND THEIR USE IN MEDICINE, AND METHODS FOR THEIR IDENTIFICATION WIVENHOE TECHNOLOGY LIMITED (GB) 1997-12-04 WO disclosed
EP-0715851-A2 Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders THE WELLCOME FOUNDATION LIMITED (GB) 1996-06-12 EP disclosed
EP-0713703-A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders THE WELLCOME FOUNDATION LIMITED (GB) 1996-05-29 EP disclosed
US-5136080-A Intermediates for glutamate inhibitors BURROUGHS WELLCOME CO. (US) 1992-08-04 US disclosed
EP-0372934-A2 Pharmacologically active CNS compounds THE WELLCOME FOUNDATION LIMITED (GB) 1990-06-13 EP disclosed
US-4544670-A ANTIPROTOZOA AGENTS, GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS WILLIAM H. RORER, INC. (US) 1985-10-01 US disclosed
EP-0116639-A4 ACYL GUANIDINES. RORER INTERNAT OVERSEAS INC (US) 1985-09-25 EP disclosed
EP-0116639-A1 ACYL GUANIDINES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1984-08-29 EP disclosed
WO-1984000875-A1 ACYL GUANIDINES RORER INT OVERSEAS (US) 1984-03-15 WO disclosed
US-4147804-A ANTIARRHYTHMIA AGENTS WILLIAM H. RORER, INC. (US) 1979-04-03 US disclosed
US-3948912-A ANTIBACTERIAL, ANTIPROTOZOA BOEHRINGER MANNHEIM G.M.B.H. (DT) 1976-04-06 US disclosed